Psilera
Tampa, Florida, United States · Biotechnology, Health Care, Science And Engineering · 9 employees
Psilera is a biotechnology company founded by scientists dedicated to finding better therapeutics for neurological conditions like dementia, addiction, and mental health disorders. Since 2019, Psilera has been focused on early-stage drug discovery & development with a dynamic team of experts in synthetic chemistry, pharmacology, clinical development, and business development.
Funding history
- Series seed — $8.8M — May 2026
- Funding Round — $2.0M — Oct 2025
- Series seed — $2.5M — Aug 2021
Recent signals
- May 28, 2026: Raised $8.8M in Series seed
- Jan 08, 2026: Psilera Appoints Magali Haas as Chief Medical Officer
- Oct 02, 2025: Raised $2.0M
- Sep 04, 2025: Psilera Appoints Scott W. Rairigh as Executive Vice President of Corporate Development
- Aug 26, 2021: Raised $2.5M in Series seed
See plans & pricing → Track Psilera’s funding, hiring, and signals — with verified contacts — on Fundz.